FDA Approved: LENALIDOMIDE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a generic lenalidomide product for Teva under ANDA201452, expanding access to lenalidomide formulations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome with 5q Deletion
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

ORIG AP for LENALIDOMIDE (LENALIDOMIDE)